Press Releases

October 23, 2012 | Press Release
WASHINGTON, DC – Today, the Office of House Majority Leader Eric Cantor released a new report entitled The Imperial Presidency to highlight the Obama administration’s massive regulatory overreach and disregard for the legislative process. The House Energy and Commerce Committee has been on the frontlines in the fight to protect jobs from the “Imperial Presidency” and restore the authority of the legislative branch as outlined under the Constitution.
October 22, 2012 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee leaders today sent letters to the New England Compounding Center and one of its former owners to seek documents related to the recent outbreak of fungal meningitis as well as the history of investigations and operations of the NECC and associated entities.
October 22, 2012 | Press Release
WASHINGTON, DC – Rep. Ed Whitfield (R-KY), Chairman of the Subcommittee on Energy and Power, has scheduled a third, bipartisan Clean Air Act forum for Thursday, November 29, 2012, at 10:00 a.m. in room 2123 of the Rayburn House Office Building. The third forum continues the theme of the first two events: “State, Local, and Federal Cooperation in the Clean Air Act.” Participants representing state, local, and tribal governments will be announced.  
October 18, 2012 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton today released a report on the committee’s activities from the 3rd quarter of the 2nd session of the 112th Congress. Prepared for members of the committee, this is the seventh such report detailing the committee’s work this Congress. The report highlights the committee’s legislative activities and successes in 2012.
October 17, 2012 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee leaders today requested additional information from the Food and Drug Administration regarding its oversight of the New England Compounding Center in Framingham, Massachusetts, which has been linked to the recent outbreak of fungal meningitis. In December 2006, the FDA sent a warning letter detailing a list of significant violations of the Food, Drug, and Cosmetic Act.
October 12, 2012 | Press Release
WASHINGTON, DC – House Energy and Commerce Committee leaders today expanded their investigation into the recent fungal meningitis outbreak linked to a contaminated injectable steroid compounded and distributed by the New England Compounding Center (NECC) in Framingham, Massachusetts. Of the 14,000 patients injected with the drug product, fourteen people have died and at least 170 people have been sickened across the nation.

Pages